Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Helen Boucher

Transplant/Immunocompromised States · Tufts

View

Dr. Sara Dong

Transplant/Immunocompromised States · Boston Children's Hospital

View

Dr. Chris Beyrer

Global Health · Duke University

View

Dr. Lance Okeke

HIV/AIDS Medicine · Duke University

View

Dr. Raphael J. Landovitz

HIV/AIDS Medicine · UCLA

View

Dr. Keith Kaye

General ID · RU

View

Dr. Aniruddha Hazra

HIV/AIDS Medicine · UCMC

View

Dr. Rochelle Walensky

General ID · Harvard Medical School

View

Dr. Kelly Dooley

Mycobacterial Disease · Vanderbilt

View

Dr. Erin Bonura

General ID · OHSU

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    DVDr. David Van Duin

    Dr. David Van Duin

    Infectious Disease · Transplant/Immunocompromised States
    University of North Carolina at Chapel Hill
    davidv

    Research

    Impact of eravacycline on fibrinogen

    2026

    Via Journal of Antimicrobial Chemotherapy

    Research

    Evaluating the antibacterial activity of ceftazidime/avibactam and aztreonam combinations against multidrug-resistant Stenotrophomonas maltophilia complex isolates in a hollow fiber infection model

    2026

    Via Clinical Microbiology and Infection

    Research

    Development of a Kidney Transplant-Specific DOOR for Urinary Tract Infections Assessing the Impact of Carbapenem Resistance

    2026

    Via Transplant Infectious Disease

    Research

    Protein Malnutrition Facilitates Intestinal Colonization with Highly Resistant Organisms

    2025

    Via bioRxiv

    Research

    A network analysis of carbapenem-resistant Klebsiella pneumoniae among healthcare facilities

    2025

    Via Scientific Reports

    Research

    How do I manage a patient with Stenotrophomonas maltophilia infection?

    2025

    Via Clinical Microbiology and Infection

    Research

    What Is Antimicrobial Resistance?

    2025

    Via JAMA

    Dec 24, 2025Editorial

    The Antibiotic Pipeline Has Delivered for Drug-Resistant Gram-Negative Pathogens, Now Global Access Must Follow.

    ​

    Written by 1 Roon author & 1 other

    Via Clinical Infectious Diseases

    Research

    A patient-centric paradigm and tool for clinical research: the DOOR is open

    2025

    Via Antimicrobial Agents and Chemotherapy

    Research

    Reviewing novel treatment options for carbapenem-resistant Acinetobacter baumannii

    2024

    Via Expert Review of Anti-Infective Therapy

    Research

    Current treatment options for pneumonia caused by carbapenem-resistant Acinetobacter baumannii

    2024

    Via Current Opinion in Infectious Diseases

    Research

    COVID-19 hospitalization risk after outpatient nirmatrelvir/ritonavir use, January to August 2022, North Carolina

    2024

    Via Journal of Antimicrobial Chemotherapy

    Jul 19, 2024Journal Article

    Participant Diversity in United States Randomized Controlled Trials of Antibacterials for Staphylococcus aureus Infections, 2000-2021.

    ​
    ​

    Written by 2 Roon authors & 10 others

    Via Clinical Infectious Diseases
    Sep 26, 2024Editorial

    Cytomegalovirus Disease: Fine-Tuning Clinical Trial Enrollment and Standardization.

    ​

    Written by 1 Roon author & 1 other

    Via Clinical Infectious Diseases

    Research

    Increased mortality in hospital- compared to community-onset carbapenem-resistant Enterobacterales infections

    2024

    Via Journal of Antimicrobial Chemotherapy